Cannabinoid receptor variety 1 antagonist suppresses progression of obesity-associated nonalcoholic steatohepatitis in a mouse style simply by remodulating disease fighting capability disturbances.
https://www.selleckchem.com/products/pyridostatin-trifluoroacetate-salt.html